Acutaas Chemicals Limited
Acutaas Chemicals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ACUTAAS and BSE: 543349 (ISIN INE00FF01025).
It has a market capitalisation of ₹26,636 crore, a last close of ₹3,253 on 2026-10-19, a one-year return of 97.5%.
Valuation: a price-to-earnings ratio of 68.97x, a price-to-book ratio of 16.11x, a dividend yield of 0.1%.
Profitability: return on equity of 24.0%, return on capital employed of 31.4%, an operating margin of 37.1%.
Growth: sales growth of 29.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.02x, promoter holding of 32.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 26,636 |
| Last close | ₹3,253 |
| P/E (TTM) | 68.97x |
| P/B | 16.11x |
| Dividend yield | 0.1% |
| ROE (FY) | 24.0% |
| ROCE (FY) | 31.4% |
| Operating margin (TTM) | 37.1% |
| Sales growth, 3-year CAGR | 29.5% |
| Debt / equity | 0.02x |
| Promoter holding | 32.7% |
| 1-year return | 97.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means